Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Amgen VP Encouraged By Initial Clinical Trial Diversity Efforts

Progress Also Made In Diversifying Management

Sep 26 2022

• By Mandy Jackson

Related Content

Q&A: BIO CEO Michelle McMurry-Heath Outlines Diversity Goals

Aug 11 2020

Amgen To Rapidly Move Olpasiran Into Phase III For Lp(a) Reduction

May 31 2022

FDA Draft Guidance Calls For Trial Diversity Plans

Apr 14 2022

Amgen Expects Quick, Broad Adoption Of Tezspire In Severe Asthma

Dec 20 2021

Has There Been A Sea Change In Trial Diversity Efforts?

Jan 12 2022

Related Companies

Amgen, Inc.

Additional Topics

Diversity & Inclusion Clinical Trials Companies Policy Strategy Research & Development BioPharmaceutical

More from Diversity & Inclusion

More from ESG

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window